ICU Management of Brain-Dead Donors Before Multi-Organ Procurement and Factors Associated With the Number of Organs Retrieved
DONOR-OBS
1 other identifier
observational
1,000
1 country
2
Brief Summary
Solid organ transplantation is the treatment of choice for end stage organ failure to improve patients' quality of life and survival. Each year, more than 5,000 solid organ transplants are performed in France, mainly from brain death donors (BDD). Approximately 1,500 BDD donors have one or more organs removed each year. Despite the growing demand for transplanted organs, the number of organs available from deceased donors has remained stable over the past few decades. This highlights the need to optimize the management of potential BDD, in order to increase both the quality and number of transplanted organs. Several studies have found an association between the characteristics and management of BDD donors and the number of organs, or even the function of transplanted organs. Data suggest that hemodynamic, respiratory, and metabolic therapeutic targets during BDD management prior to multi-organ procurement were associated with a higher number of transplanted organs compared to standard care. However, this has never been confirmed in a French population. Furthermore, while the impact of these therapeutic goals has been studied after the donor is in a state of brain death, the events occurring in the ICU before reaching brain death status and their impact on the number of organs retrieved have not been investigated. Lastly, the intensity of the therapeutic interventions used to achieve these goals, and certain management delays, have only been partially studied. Our hypothesis is that achieving a bundle of therapeutic goals, and the intensity of the interventions used to reach these goals, both before and after BDD, are associated with a greater number of organs retrieved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2024
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedStudy Start
First participant enrolled
April 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2026
CompletedMay 16, 2025
May 1, 2025
10 months
December 23, 2024
May 13, 2025
Conditions
Outcome Measures
Primary Outcomes (9)
Mean arterial pressure
Mean arterial pressure (MAP) between 60 and 110 mmHg
Between admission to intensive care and brain death and before multi-organ retrieval
Central venous pressure
Central venous pressure (CVP) between 4 and 12 mmHg
Within 7 last days before brain death and before multi-organ retrieval
Left ventricular ejection fraction
Left ventricular ejection fraction (LVEF) ≥ 50%
Between admission to intensive care and brain death and before multi-organ retrieval
vasopressor
Low doses and a single vasopressor. (≤10 µg/kg/min of dopamine or ≤60 µg/min of Neosynephrine or ≤10 µg/min of norepinephrine))
Between admission to intensive care and brain death and before multi-organ retrieval
Arterial pH
Arterial pH between 7.3 and 7.5
Between admission to intensive care and brain death and before multi-organ retrieval
PaO2/FiO2
PaO2/FiO2 ≥ 300
Between admission to intensive care and brain death and before multi-organ retrieval
Sodium levels
Sodium levels ≤ 155 mmol/L
Between admission to intensive care and brain death and before multi-organ retrieval
Diuresis
Diuresis ≥ 0.5 mL/kg/h
Between admission to intensive care and brain death and before multi-organ retrieval
Blood glucose
Blood glucose ≤ 1.5 g/L
Between admission to intensive care and brain death and before multi-organ retrieval
Secondary Outcomes (12)
demographics of Brain dead
Between admission to intensive care and brain death and before multi-organ retrieval
Causes of neurological injury leading to brain death
Between admission to intensive care and brain death and before multi-organ retrieval
Timelines and durations of patient management before and after brain death
Between admission to intensive care and brain death and before multi-organ retrieval
Incidence of organ failures before and after brain death
Between admission to intensive care and brain death and before multi-organ retrieval
Incidence of acute kidney failure before and after brain death
Between admission to intensive care and brain death and before multi-organ retrieval
- +7 more secondary outcomes
Study Arms (1)
Organ donation
Patients over 18 years of age, hospitalized in the ICU In a state of brain death No objection to organ donation during their lifetime
Interventions
to enhance the understanding of the factors associated with the number of organs retrieved from patients admitted to the ICU for organ donation
Eligibility Criteria
Patients in a state of brain dead. Patients meeting the inclusion criteria from January 1, 2022, to December 31, 2024, will be included in the study.
You may qualify if:
- Patients over 18 years of age, hospitalized in the ICU
- In a state of brain death
- No objection to organ donation during their lifetime
- Patients with social security coverage
You may not qualify if:
- Objection to the use of their data during their lifetime
- Registration in the national refusal registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital Saint-Louis, AP-HP
Paris, 75010, France
Hôpital Pitié Salpêtrière AP-HP
Paris, 75013, France
Related Publications (6)
Malinoski DJ, Patel MS, Daly MC, Oley-Graybill C, Salim A; UNOS Region 5 DMG workgroup. The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med. 2012 Oct;40(10):2773-80. doi: 10.1097/CCM.0b013e31825b252a.
PMID: 22846779BACKGROUNDOniscu GC, Rockell K, Martin DE. Challenges in undertaking research in transplantation. Lancet. 2025 Mar 1;405(10480):681-683. doi: 10.1016/S0140-6736(24)00931-0. Epub 2024 May 21. No abstract available.
PMID: 38788740BACKGROUNDiomedecine, P. Chiffres 2022 de l'activité de prélèvement et de greffe d'organes et de tissus et Baromète 2023 sur la connaissance et la perception du don d'organes en France.
BACKGROUNDPatel MS, De La Cruz S, Sally MB, Groat T, Malinoski DJ. Active Donor Management During the Hospital Phase of Care Is Associated with More Organs Transplanted per Donor. J Am Coll Surg. 2017 Oct;225(4):525-531. doi: 10.1016/j.jamcollsurg.2017.06.014. Epub 2017 Jul 21.
PMID: 28739153RESULTBera KD, Shah A, English MR, Harvey D, Ploeg RJ. Optimisation of the organ donor and effects on transplanted organs: a narrative review on current practice and future directions. Anaesthesia. 2020 Sep;75(9):1191-1204. doi: 10.1111/anae.15037. Epub 2020 May 19.
PMID: 32430910RESULTPatel MS, Zatarain J, De La Cruz S, Sally MB, Ewing T, Crutchfield M, Enestvedt CK, Malinoski DJ. The impact of meeting donor management goals on the number of organs transplanted per expanded criteria donor: a prospective study from the UNOS Region 5 Donor Management Goals Workgroup. JAMA Surg. 2014 Sep;149(9):969-75. doi: 10.1001/jamasurg.2014.967.
PMID: 25054379RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2024
First Posted
January 10, 2025
Study Start
April 23, 2025
Primary Completion
February 15, 2026
Study Completion
February 15, 2026
Last Updated
May 16, 2025
Record last verified: 2025-05